Vimarsana
Biggest News Aggregation in the World

Page 4 - Atento Sa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Atento Sa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Atento Sa Today - Breaking & Trending Today

Atento Reports Fiscal 2022 Second Quarter and First Half Results - Vimarsana News

Atento Reports Fiscal 2022 Second Quarter and First Half Results

Demanding quarter, but management believes positive inflection point has been reached with strong 2H trend underway Record June sales of $34 million, growing...

Annual and Extraordinary Shareholders' Meeting of Atento, S.A. held in Luxembourg in June 29th 2022 with 80.89% participation - Vimarsana News

Annual and Extraordinary Shareholders' Meeting of Atento, S.A. held in Luxembourg in June 29th 2022 with 80.89% participation

/PRNewswire/ -- Atento S.A. (NYSE: ATTO, "Atento" or the "Company"), one of the largest providers worldwide and the leading company in customer relationship...

Atento renews its organization with three new appointments that strengthen its strategy, including new CFO - Vimarsana News

Atento renews its organization with three new appointments that strengthen its strategy, including new CFO

Atento reorganizes its regional structure switching from five regions to three to optimize the efficiency of its operations and improve proximity and service...

Atento Announces Cooperation Agreement with Investors - Vimarsana News

Atento Announces Cooperation Agreement with Investors

/PRNewswire/ -- Atento S.A. (NYSE: ATTO) ("Atento" or the "Company"), one of the largest providers worldwide and the leading company in customer relationship...

Stock Analysts' Upgrades for June 1st (APLT, ARHS, ASTS, ATHX, ATNM, ATTO, AURA, AVDX, BAK, BBLN) - Vimarsana News

Stock Analysts' Upgrades for June 1st (APLT, ARHS, ASTS, ATHX, ATNM, ATTO, AURA, AVDX, BAK, BBLN)

Stock Analysts’ upgrades for Wednesday, June 1st: Applied Therapeutics (NASDAQ:APLT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $1.50 target price on the stock. According to Zacks, “Applied Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in developing drug candidates for unmet […]